{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:40:07Z","timestamp":1706748007886},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1016\/j.pnpbp.2005.10.010","type":"journal-article","created":{"date-parts":[[2005,11,22]],"date-time":"2005-11-22T12:31:18Z","timestamp":1132662678000},"page":"239-243","source":"Crossref","is-referenced-by-count":13,"title":["Effects of clozapine plus lamotrigine on phencyclidine-induced hyperactivity"],"prefix":"10.1016","volume":"30","author":[{"given":"Harriet J.","family":"Williams","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina R.","family":"Zamzow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harold","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serdar M.","family":"Dursun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2005.10.010_bib1","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1001\/archpsyc.57.3.270","article-title":"Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methyl-d-aspartate receptor antagonists","volume":"57","author":"Anand","year":"2000","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pnpbp.2005.10.010_bib2","first-page":"787","article-title":"Clozapine antagonizes phencyclidine-induce deficits in sensorimotor gating of the startle response","volume":"271","author":"Bakshi","year":"1994","journal-title":"J. Pharm. Exp."},{"key":"10.1016\/j.pnpbp.2005.10.010_bib3","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1093\/oxfordjournals.schbul.a006901","article-title":"When symptoms persist: clozapine augmentation strategies","volume":"27","author":"Buckley","year":"2001","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.pnpbp.2005.10.010_bib4","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/sj.bjp.0703406","article-title":"Blockade of phencyclidine-induced effects by a nitric oxide donor","volume":"130","author":"Bujas-Bobanovic","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2005.10.010_bib5","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1176\/appi.ajp.157.9.1523","article-title":"Lamotrigine and clozapine for bipolar disorder","volume":"157","author":"Calabrese","year":"2000","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2005.10.010_bib6","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1176\/ajp.156.7.1019","article-title":"Spectrum of activity of lamotrigine in treatment-refractory bipolar disorder","volume":".156","author":"Calabrese","year":"1999","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2005.10.010_bib7","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1192\/S0007125000293574","article-title":"A glutamatergic deficiency model of schizophrenia","volume":"174","author":"Carlsson","year":"1999","journal-title":"Br. J. Psychiatry"},{"issue":"Suppl. 4","key":"10.1016\/j.pnpbp.2005.10.010_bib8","doi-asserted-by":"crossref","first-page":"IV37","DOI":"10.1007\/PL00014183","article-title":"Neurotransmitter interactions in schizophrenia-therapeutic implications","volume":"249","author":"Carlsson","year":"1999","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.pnpbp.2005.10.010_bib9","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/S0006-8993(00)03067-5","article-title":"Dopamine and 5-HT turnover are increased by the mGLU2\/3 receptor agonist LY379268 in rat medial prefrontal cortex, nucleus accumbens and striatum","volume":"887","author":"Cartmell","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.pnpbp.2005.10.010_bib10","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S0028-3908(01)00034-X","article-title":"Acute increases in monoamine release in rat prefrontal cortex by the mGlu2\/3 agonist LY379268 are similar in profile to risperidone, not locally mediated, and can be elicited in the presence of uptake blockade","volume":"40","author":"Cartmell","year":"2001","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2005.10.010_bib11","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/oxfordjournals.schbul.a033463","article-title":"Clozapine augmentation: safety and efficacy","volume":"26","author":"Chong","year":"2000","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.pnpbp.2005.10.010_bib12","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1016\/S0028-3908(00)00051-4","article-title":"The anticonvulsant, lamotrigine decreases spontaneous glutamate release but increases spontaneous GABA release in the rat entorhinal cortex in vitro","volume":"39","author":"Cunningham","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2005.10.010_bib13","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0022-3956(96)00042-8","article-title":"A two process theory of schizophrenia: evidence from studies in post-mortem brain","volume":"31","author":"Deakin","year":"1997","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.pnpbp.2005.10.010_bib14","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1111\/j.1471-4159.1989.tb07257.x","article-title":"Frontal cortical and left temporal glutamatergic dysfunction in schizophrenia","volume":"52","author":"Deakin","year":"1989","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pnpbp.2005.10.010_bib15","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/026988119701100206","article-title":"Familial and developmental abnormalities of frontal lobe function and chemistry in schizophrenia","volume":"11","author":"Deakin","year":"1997","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2005.10.010_bib16","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/sj.mp.4000581","article-title":"Mechanisms of typical and atypical drug action in relation to dopamine and NMDA hypofunction hypotheses of schizophrenia","volume":"4","author":"Duncan","year":"1999","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2005.10.010_bib17","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1177\/026988110101500409","article-title":"Augmenting antipsychotic treatment with lamotrigine or topiramate in patients with treatment-resistant schizophrenia: a naturalistic case-series outcome study","volume":"15","author":"Dursun","year":"2001","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2005.10.010_bib18","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1001\/archpsyc.56.10.950","article-title":"Clozapine plus lamotrigine in treatment-resistant schizophrenia","volume":"56","author":"Dursun","year":"1999","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pnpbp.2005.10.010_bib19","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1176\/ajp.148.10.1301","article-title":"Recent advances in the phencyclidine model of schizophrenia","volume":"148","author":"Javitt","year":"1991","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2005.10.010_bib20","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0893-133X(98)00060-8","article-title":"The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia","volume":"20","author":"Jentsch","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2005.10.010_bib21","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.biopsych.2004.06.029","article-title":"Placebo-controlled trial of lamotrigine added to conventional and atypical antipsychotics in schizophrenia","volume":"56","author":"Kremer","year":"2004","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2005.10.010_bib22","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0304-3940(03)00523-8","article-title":"Clozapine inhibits isolated N-methyl-d-aspartate receptors expressed in xenopus oocytes in a subunit specific manner","volume":"346","author":"Levine","year":"2003","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pnpbp.2005.10.010_bib23","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0304-3940(93)90370-Z","article-title":"Anti-glutamatergic effects of clozapine","volume":"163","author":"Lidsky","year":"1993","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pnpbp.2005.10.010_bib24","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1126\/science.281.5381.1349","article-title":"Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats","volume":"281","author":"Moghaddam","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.pnpbp.2005.10.010_bib25","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1001\/archneur.1997.00550220042012","article-title":"Excitotoxic neurodegeneration in Alzheimer disease. New hypothesis and new therapeutic strategies","volume":"54","author":"Olney","year":"1997","journal-title":"Arch. Neurobiol."},{"key":"10.1016\/j.pnpbp.2005.10.010_bib26","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0920-9964(99)00115-2","article-title":"Comparative pharmacology of bipolar disorder and schizophrenia","volume":"39","author":"Post","year":"1999","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.pnpbp.2005.10.010_bib27","first-page":"1058","article-title":"Induction patterns of Fos-like immunoreactivity in the forebrain as predictors of atypical antipsychotic activity","volume":"271","author":"Robertson","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pnpbp.2005.10.010_bib28","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/0028-3908(84)90041-8","article-title":"Direct effect of neuroleptics on glutamate release","volume":"23","author":"Sherman","year":"1984","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2005.10.010_bib29","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0006-3223(98)00077-8","article-title":"Comparison of glutamate and GABA uptake binding sites in frontal and temporal lobes in schizophrenia","volume":"44","author":"Simpson","year":"1998","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2005.10.010_bib30","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0166-4328(95)00162-X","article-title":"The behavioural and neurochemical effects of PCP in humans and animals: some implications for modeling psychosis","volume":"74","author":"Steinpreis","year":"1996","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pnpbp.2005.10.010_bib32","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/j.1875-9114.1996.tb02920.x","article-title":"A review of NMDA receptors and the phencyclidine model of schizophrenia","volume":"16","author":"Thornberg","year":"1996","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.pnpbp.2005.10.010_bib33","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/S0006-3223(03)00524-9","article-title":"Lamotrigine in treatment-resistant schizophrenia; a randomized placebo-controlled cross over trial","volume":"54","author":"Tiihonen","year":"2003","journal-title":"Biol. Psychiatry"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584605003179?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584605003179?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:27:47Z","timestamp":1706747267000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584605003179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["S0278584605003179"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2005.10.010","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2006,3]]}}}